EPG Wealth Management LLC Invests $766,000 in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

EPG Wealth Management LLC bought a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 9,801 shares of the company’s stock, valued at approximately $766,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. CoreFirst Bank & Trust acquired a new stake in GE HealthCare Technologies during the 4th quarter worth approximately $25,000. Runnymede Capital Advisors Inc. bought a new position in shares of GE HealthCare Technologies during the fourth quarter worth approximately $28,000. LGT Financial Advisors LLC raised its position in shares of GE HealthCare Technologies by 46.2% in the fourth quarter. LGT Financial Advisors LLC now owns 389 shares of the company’s stock valued at $30,000 after buying an additional 123 shares in the last quarter. Accredited Wealth Management LLC acquired a new stake in GE HealthCare Technologies during the fourth quarter worth approximately $30,000. Finally, Bank of Jackson Hole Trust bought a new position in GE HealthCare Technologies during the 4th quarter worth $32,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 3.2 %

Shares of NASDAQ:GEHC opened at $67.17 on Wednesday. The company has a market capitalization of $30.76 billion, a price-to-earnings ratio of 15.51, a P/E/G ratio of 3.19 and a beta of 1.21. The business’s 50-day moving average is $73.47 and its 200-day moving average is $81.05. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.10. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $4.78 billion for the quarter, compared to the consensus estimate of $4.66 billion. During the same quarter in the previous year, the company earned $0.90 EPS. GE HealthCare Technologies’s quarterly revenue was up 2.7% compared to the same quarter last year. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.21%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies’s payout ratio is 2.95%.

GE HealthCare Technologies declared that its Board of Directors has initiated a share repurchase plan on Wednesday, April 30th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the company to repurchase up to 3.1% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of research firms recently commented on GEHC. Citigroup dropped their price target on GE HealthCare Technologies from $105.00 to $86.00 and set a “buy” rating for the company in a research note on Wednesday, April 30th. BTIG Research set a $95.00 price objective on shares of GE HealthCare Technologies and gave the company a “buy” rating in a research note on Monday, April 14th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. The Goldman Sachs Group reduced their price objective on GE HealthCare Technologies from $94.00 to $82.00 and set a “buy” rating on the stock in a research note on Thursday, May 1st. Finally, Piper Sandler dropped their target price on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an “overweight” rating for the company in a report on Wednesday, April 23rd. Three analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.27.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.